Limbic raises £11m in Series A funding led by Khosla Ventures to expand into the US market.
The financing round was led by Khosla Ventures with participation from Gaingels and Illusian.
Limbic builds clinical mental health artificial intelligence technology designed to assist healthcare providers and patients. Its systems are deployed within public health services to streamline patient onboarding and expand care access.
Mental health technology developer Limbic has secured £11m in a Series A funding round to support its expansion into the United States. The investment was led by Khosla Ventures, with participation from new backers including Gaingels and Illusian.
The capital will enable the company to introduce its clinically validated artificial intelligence solutions to American health systems and payers. Limbic's technology has previously been adopted across the National Health Service in the United Kingdom, where it has assisted hundreds of thousands of patients and freed up clinical hours.
Research published in Nature Medicine indicates that the firm's platform has also improved engagement among ethnic and sexual minority groups. The latest financing will back further scaling of these regulatory-compliant systems globally.
From the founder
"The global behavioral healthcare sector is grappling with a critical workforce supply challenge. Care providers are experiencing burnout, and services are stretched thin, operating on slim margins."
Ross Harper
CEO and co-founder at Limbic
Investor perspective
"There is a grave shortage of mental healthcare providers across the globe. AI will allow us to realize the potential of near-free access to such care for everyone, independent of provenance and socioeconomic status. Limbic is at the forefront of this important and ambitious goal, and we are proud to partner with them."
Vinod Khosla
founder, Khosla Ventures
Use of funds
- 01Expand into international markets
